Lifestyle factors and Alzheimer's disease prevention

Professor Kenneth Kosik discusses lifestyle factors that will delay onset of Alzheimer’s disease. These include diet, exercise, controlling hypertension, and not smoking.

The question often comes up about how we might prevent Alzheimer’s disease or delay its onset. This is a very exciting area right now because it turns out that there actually are things that we can all do, non-pharmacological things we can all do, that will delay its onset. The word has to get out about these interventions because they really can have an impact. They are things that will not surprise you. For instance, controlling cardiovascular risk factors – we know that if you are able to control hypertension, keep your cholesterol down, have a good diet and engage in exercise, stop smoking, control diabetes – all of those things not only affect the heart and the blood vessels in your body, but also affect your brain. The brain is an organ, like any other organ in your body, and reducing cardiovascular risk factors is not just prevention for heart attacks but is also prevention for Alzheimer’s disease. So we can work a lot harder to, I think, have an impact on this disease in that manner.

alzheimer's, alzheimer, prevention, cardiovascular, risk factors, lifestyle, diet, exercise, diabetes, smoking , cholesterol, kenneth, kosik

Related Content

2034. Mild Cognitive Impairment

Professor Kenneth Kosik discusses the relationship between mild cognitive impairment (MCI) and Alzheimer’s disease. MCI is a predictor of Alzheimer's disease.

  • ID: 2034
  • Source: G2C

801. Environment and Alzheimer's Disease

Researchers shed new light on how diet, exercise, red wine consumption, and stress may lower or raise disease risk.

  • ID: 801
  • Source: G2C

2227. Alzheimer's disease

An overview of Alzheimer's disease-related content on Genes to Cognition Online.

  • ID: 2227
  • Source: G2C

2033. Amyloid precursor protein and Alzheimer's disease

Professor Kenneth Kosik describes the relationship between the amyloid precursor protein (APP) and Alzheimer’s disease. APP mutations are linked to early-onset Alzheimer’s disease.

  • ID: 2033
  • Source: G2C

2027. Alzheimer’s disease - early onset

Professor Kenneth Kosik discusses early-onset Alzheimer's disease, which affects 1% of all people with the disease.

  • ID: 2027
  • Source: G2C

2025. What is Alzheimer's disease?

Professor Kenneth Kosik defines Alzheimer's disease as a slowly progressing illness that deteriorates the brain and impairs many major cognitive functions.

  • ID: 2025
  • Source: G2C

2190. Late-onset genes for Alzheimer's disease

Professor Donna Wilcock discusses the late-onset gene for Alzheimer's disease, ApoE4, which increases the risk of developing the disease.

  • ID: 2190
  • Source: G2C

2032. Neuropathology of Alzheimer's disease

Professor Kenneth Kosik discusses some of the brain regions specifically associated with Alzheimer's disease, including the hippocampus, amygdala, and entorhinal cortex.

  • ID: 2032
  • Source: G2C

2031. Alzheimer's disease - selective neuropathology

Professor Kenneth Kosik discusses the neuropathology of Alzheimer's disease, which affects the hippocampus, amygdala, and cortical areas. Areas, such as the cerebellum, are unaffected.

  • ID: 2031
  • Source: G2C

794. Background to Alzheimer's Disease

Alzheimer’s disease is a progressive brain disorder that causes a gradual and irreversible loss of higher brain functions, including memory, language skills, and perception of time and space,

  • ID: 794
  • Source: G2C